Phase 3 Lymphoma Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• The patient was diagnosed with Acute Lymphoblastic Leukemia (ALL) when they were between 1 and 365 days old (i.e., during their first year of life)
• The patient is starting their initial treatment (induction therapy) within the timeframe that the study is currently enrolling participants
• The diagnosis of ALL has been confirmed through specific laboratory tests examining the cancer cells in the bone marrow (note: patients with a specific type called B-cell/Burkitt ALL cannot join)
• The patient's parents or legal guardians have given their written agreement for the patient to be treated at one of the clinics taking part in this study

Who may not be able to join:

• The current illness is a return (relapse) of ALL that was previously misdiagnosed and not treated correctly the first time
• The patient has a serious additional health condition that would make it very difficult to safely give chemotherapy, such as major birth defects, heart problems, or metabolic disorders
• There is not enough information available to properly classify the type of leukemia or decide which treatment group the patient belongs to (confirm with trial site)
• The patient has already received cancer-killing (cytotoxic) drugs over a long period of time before this trial
• The patient's treatment has already deviated from the study's standard plan in ways not covered by the protocol and not caused by treatment side effects or disease complications

Important: Always verify eligibility with the trial site directly before applying.